Get started
MICROBIX BIOSYSTEMSMICROBIX BIOSYSTEMSMICROBIX BIOSYSTEMS

MICROBIX BIOSYSTEMS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MBX chart


Full chart

MBX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪53.81 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
14.455
Basic EPS (TTM)
0.025 CAD
Net income (FY)
‪3.52 M‬ CAD
Revenue (FY)
‪25.39 M‬ CAD
Shares float
‪113.25 M‬
Beta (1Y)
−1.13

About MICROBIX BIOSYSTEMS


Sector
Health Technology
Industry
Biotechnology
CEO
Cameron L. Groome
Website
microbix.com
Headquarters
Mississauga
Founded
1988
FIGI
BBG000CB00R1
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. It operates through the Antigens, QAPs and DxTM, and Other segments. The Antigens, QAPs and DxTM segment includes the development, manufacturing and sales of products relating to the medical diagnostics industry. The Other segment deals with the development and commercialization of novel and proprietary products or technologies such as Kinlytic. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MBX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MBX is 0.400 CAD — it has increased by 8.11% in the past 24 hours. Watch MICROBIX BIOSYSTEMS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange MICROBIX BIOSYSTEMS stocks are traded under the ticker MBX.
MBX stock has risen by 15.94% compared to the previous week, the month change is a 29.03% rise, over the last year MICROBIX BIOSYSTEMS has showed a 11.11% increase.
We've gathered analysts' opinions on MICROBIX BIOSYSTEMS future price: according to them, MBX price has a max estimate of 0.90 CAD and a min estimate of 0.90 CAD. Watch MBX chart and read a more detailed MICROBIX BIOSYSTEMS stock forecast: see what analysts think of MICROBIX BIOSYSTEMS and suggest that you do with its stocks.
MBX reached its all-time high on Mar 6, 2000 with the price of 1.900 CAD, and its all-time low was 0.120 CAD and was reached on Jul 24, 2013. View more price dynamics on MBX chart.
See other stocks reaching their highest and lowest prices.
MBX stock is 8.00% volatile and has beta coefficient of −1.13. Track MICROBIX BIOSYSTEMS stock price on the chart and check out the list of the most volatile stocks — is MICROBIX BIOSYSTEMS there?
Today MICROBIX BIOSYSTEMS has the market capitalization of ‪53.81 M‬, it has increased by 10.14% over the last week.
Yes, you can track MICROBIX BIOSYSTEMS financials in yearly and quarterly reports right on TradingView.
MICROBIX BIOSYSTEMS is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
MICROBIX BIOSYSTEMS revenue for the last quarter amounts to ‪6.29 M‬ CAD, despite the estimated figure of ‪5.60 M‬ CAD. In the next quarter, revenue is expected to reach ‪5.80 M‬ CAD.
MBX net income for the last quarter is ‪440.32 K‬ CAD, while the quarter before that showed ‪246.75 K‬ CAD of net income which accounts for 78.45% change. Track more MICROBIX BIOSYSTEMS financial stats to get the full picture.
No, MBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROBIX BIOSYSTEMS EBITDA is ‪5.52 M‬ CAD, and current EBITDA margin is 21.73%. See more stats in MICROBIX BIOSYSTEMS financial statements.
Like other stocks, MBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROBIX BIOSYSTEMS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROBIX BIOSYSTEMS technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROBIX BIOSYSTEMS stock shows the buy signal. See more of MICROBIX BIOSYSTEMS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.